Cytarabine (Hospira, Inc.)
Welcome to the PulseAid listing for the Cytarabine drug offered from Hospira, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | CYTARABINE |
SUBSTANCE NAME: | CYTARABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1999-11-22 |
END MARKETING DATE: | 0000-00-00 |
Cytarabine HUMAN PRESCRIPTION DRUG Details:
Item Description | Cytarabine from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 1999-11-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61703-319_65f71161-db35-457d-8789-7f30832adbf9 |
PRODUCT NDC: | 61703-319 |
APPLICATION NUMBER: | ANDA075383 |
Other CYTARABINE Pharmaceutical Manufacturers / Labelers: